Search

everythinglearnresearchcommunity

for

Search:↓

Insured Hispanics had more dermatology visits, while non-Hispanic Blacks and whites did not, with fewer visits for those with public insurance.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

Hispanic individuals in Northern Nevada were more affected by COVID-19 but had lower mortality rates than non-Hispanics.

Hispanics in Northern Nevada had more COVID-19 cases but lower mortality than non-Hispanics.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

COVID-19 affected Black communities more in Oakland County, MI, but didn't increase death rates.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

Dermatology datasets need more diversity in skin tones and ethnic representation.

Racial minorities faced more Covid-19 blame due to anti-fatness and structural racism.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

Non-Hispanic Black and Hispanic female service members have the highest rates of hair loss.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Men and minority groups face higher risks and severe outcomes from SARS-CoV, MERS-CoV, and COVID-19.

Improving education, training, and access to affordable treatments is crucial for better managing inflammatory skin diseases in Latin America.

PCOS diagnosis and treatment should consider race and ethnicity for accuracy.

Men had worse COVID-19 outcomes than women in New York City.

More research is needed to understand sex and racial differences in long COVID.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Ethnic hair products contain different allergens than nonethnic ones, with fragrance being the most common in ethnic products.

Age, health conditions, race, and gender affect COVID-19 risk.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Gender and social factors, not just biology, affect COVID-19 death rates.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Dermatologists need better training on ethnic hair care to improve patient care and satisfaction.

Black and Hispanic women are more likely to have alopecia areata than white women.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.